You are here: / / U.S. FDA Declines to Approve Eli Lilly & Incyte Arthritis Drug
Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.